Atlas Trials

Role of Neutrophil CD64 and Monocyte HLA-DR Markers in the Dignosis of Neonatal Sepsis

Clinical trial NCT05985174 · UNKNOWN

Trial details

NCT number
NCT05985174
Sponsor
Sohag University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Neonatal Sepsis
Start date
2023-08-01
Primary completion
2024-08-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.